中重度子宫内膜异位症经腹腔镜联合不同药物治疗的临床观察

黄亚敏，张华

（陕西省兴平市西城区一四五医院妇产科，陕西 咸阳，713100）

浏览次数：60次 下载次数：368次

摘要：

目的 分析中重度子宫内膜异位症经腹腔镜联合药物治疗的临床效果。方法 选取我院收治的50例中重度子宫内膜异位症患者为研究对象，将采用腹腔镜联合GnRH-a 治疗的25例患者列为治疗组，将采用腹腔镜联合孕三烯酮治疗的25例患者列为对照组，比较两组患者临床疗效。结果 治疗组症状总缓解率为100.0%，高于对照组的84.0%（P<0.05）；治疗组妊娠率为64.0%，高于对照组的32.0%（P<0.05）；治疗组复发率为24.0%，低于对照组的56.0%（P<0.05）；两组不良反应发生率差异不显著（P>0.05）。结论 腹腔镜术后联合GnRH-a 治疗中重度子宫内膜异位症疗效确切。

关键词：中重度子宫内膜异位症；腹腔镜；孕三烯酮

中图分类号：R713 文献标志码：A文章编号：2096-1413(2017)23-0068-02

Clinical observation of laparoscopy combined different drug therapy on moderate and severe endometriosis
HUANG Ya-min, ZHANG Hua
(Department of Obstetrics and Gynecology, No.145 Hospital of Xicheng District of Xingping, Xianyang 713100, China)

ABSTRACT: Objective To analyze the clinical effect of laparoscopy combined different drug therapy on moderate and severe endometriosis. Methods Fifty patients with moderate or severe endometriosis admitted in our hospital were selected as study objects. Twenty-five patients who underwent laparoscopy combined with GnRH-a were included in the treatment group, while twenty-five patients who were treated with laparoscopy combined with gestrinone were included in the control group. The clinical efficacy of the two groups were compared. Results The total remission rate of the treatment group was 100.0%, which was higher than 84.0% in the control group (P<0.05); of the treatment group was 64.0%, which were higher than 32.0% of the control group (P<0.05); the relapse rate of the treatment group was 24.0%, which was lower than 56.0% of the control group (P<0.05); the difference in the incidence rate of adverse reaction between the two groups was not significant (P>0.05). Conclusion Laparoscopy combined with GnRH-a applied on moderate and severe endometrios is effective.
KEYWORDS: moderate to severe endometriosis; laparoscopy; gestrinone

参考文献：
[1] 胡晓军,刘玉玲,党群.重度子宫内膜异位症腹腔镜术后应用GnRHa及反向添加疗法的临床效果[J].实用医学杂志,2014,30(4):557-560.
[2] 刘芬芳,左云海,龙浪,等.重度子宫内膜异位症患者腹腔镜术后应用不同药物的疗效比较[J].河北医学,2015,21(1):104-106.
[3] 王敏,于力,周玲,等.腹腔镜保守性手术后联合促性腺激素释放激素治疗子宫内膜异位症的荟萃分析[J].中华医学杂志,2013,93(39):3128-3130.
[4] 杨琴.米非司酮治疗子宫内膜异位症的疗效及其机制探讨[J].山东医药,2013,53(48):52-53.
[5] 张小莎,黄作香,李萍,等.GnRHa 联合反向添加戊酸雌二醇对重度子宫内膜异位症腹腔镜术后患者的疼痛感及远期复发率影响[J].中国生化药物杂志,2016,41(1):134-136.
[6] 黄翠燕.GnRHa 联合反加疗法治疗保守性手术后中、重度子宫内膜异位症临床分析[J].海南医学,2014,25(11):1663-1665.
[7] 胡晓军,刘玉玲,党群，等援重度子宫内膜异位症腹腔镜术后应用 GnRHa 及反向添加疗法的临床效果[J].实用医学杂志,2014,30(4):557-560.
[8] 李琳,成莉,周敏,等.腹腔镜联合药物治疗重度于官内膜异位症疗效观察[J].中国医药导报,2012,9(34):71-72.